AMRX Amneal Pharmaceuticals, Inc.

Fundamentals / CIK 0001723128 / USD

Amneal Pharmaceuticals, Inc. reported $3.20B in revenue and net income of $133.3M for the trailing twelve months ended September 30, 2026 (up 10.0% year over year), with a 40.2% gross margin and a 15.0% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open AMRX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$3.04B$1.52B$0-$820.9MFY 2016 Revenue: $1.02BFY 2016 Net Income: $02016FY 2017 Revenue: $1.03BFY 2017 Net Income: $02017FY 2018 Revenue: $1.66BFY 2018 Net Income: -$19.74M2018FY 2019 Revenue: $1.63BFY 2019 Net Income: -$603.6M2019FY 2020 Revenue: $1.99BFY 2020 Net Income: $67.79M2020FY 2021 Revenue: $2.09BFY 2021 Net Income: $13.16M2021FY 2022 Revenue: $2.21BFY 2022 Net Income: -$270.6M2022FY 2023 Revenue: $2.39BFY 2023 Net Income: -$83.99M2023FY 2024 Revenue: $2.79BFY 2024 Net Income: -$116.9M2024FY 2025 Revenue: $3.02BFY 2025 Net Income: $72.06M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $3.02B $2.79B $2.39B $2.21B $2.09B $1.99B $1.63B $1.66B $1.03B $1.02B
Cost of Revenue $1.91B $1.77B $1.57B $1.43B $1.32B $1.33B $1.15B $938.8M $507.5M $420.8M
Gross Profit $1.11B $1.02B $820.6M $784.7M $769.0M $628.4M $353.0M $716.4M $526.2M $597.5M
Research & Development $186.2M $190.7M $163.9M $195.7M $201.8M $179.9M $188.0M $194.2M $171.4M $179.0M
Selling, General & Admin $526.8M $476.4M $429.7M $399.7M $365.5M $326.7M $289.6M $227.8M $109.0M $118.8M
Operating Income $394.1M $249.3M $204.4M -$94.93M $152.7M $91.16M -$248.7M -$19.67M $245.1M $284.9M
EBITDA $617.7M $485.5M $433.8M $145.3M $386.1M $326.5M -$41.45M $188.7M $360.1M $317.9M
Income Before Tax $139.2M -$55.01M -$40.27M -$248.1M $31.37M -$35.78M -$220.2M -$202.7M $171.3M $214.8M
Income Tax Expense $11.28M $18.86M $8.45M $6.66M $11.20M -$104.4M $383.3M -$1.42M $2.00M $5.39M
Net Income $72.06M -$116.9M -$83.99M -$270.6M $13.16M $67.79M -$603.6M -$19.74M $0 $0
Basic EPS $0.23 -$0.38 -$0.48 -$0.86 $0.07 $0.62 -$2.74 -$0.16 -- --
Diluted EPS $0.22 -$0.38 -$0.48 -$0.86 $0.07 $0.61 -$2.74 -$0.16 -- --
Basic Shares Outstanding 313.4M 309.0M 176.1M 150.9M 148.9M 147.4M 132.1M 127.3M -- --
Diluted Shares Outstanding 324.8M 309.0M 176.1M 150.9M 151.8M 148.9M 132.1M 127.3M -- --

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $862.7M $796.2M $722.5M $814.3M $784.5M $724.5M $695.4M $730.5M
Cost of Revenue $528.6M $461.7M $402.4M $517.1M $510.5M $438.3M $439.5M $467.6M
Gross Profit $334.1M $334.5M $320.1M $297.2M $274.0M $286.3M $255.9M $262.9M
Research & Development $68.37M $39.02M $38.38M $34.82M $63.35M $47.96M $40.04M $54.27M
Selling, General & Admin $139.6M $148.7M $138.9M $146.5M $137.8M $124.3M $118.3M $128.7M
Operating Income $95.42M $129.8M $141.8M $112.0M $70.34M $111.4M $100.3M $75.79M
EBITDA $148.7M -- -- -- $124.4M -- -- --
Income Before Tax $15.06M $70.99M $80.18M $55.23M -$5.22M $51.71M $37.49M -$15.32M
Income Tax Expense $2.75M $1.38M $2.18M $5.66M -$23.36M $16.10M $12.87M $5.42M
Net Income -$21.70M $57.66M $62.26M $35.08M $2.37M $22.42M $12.20M -$31.08M
Basic EPS -$0.06 $0.18 $0.20 -- $0.01 $0.07 $0.04 --
Diluted EPS -$0.06 $0.18 $0.19 -- $0.01 $0.07 $0.04 --
Basic Shares Outstanding 335.7M 319.2M 316.0M -- 314.2M 313.7M 311.1M --
Diluted Shares Outstanding 335.7M 328.1M 328.9M -- 324.8M 322.4M 324.0M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $282.0M $110.6M $91.54M $25.98M $247.8M $341.4M $151.2M $213.4M $74.17M
Cash & Short-Term Investments $282.0M $110.6M $91.54M $25.98M $247.8M $341.4M $151.2M $213.4M $74.17M
Accounts Receivable, Net -- -- -- $741.8M $662.6M $638.9M $604.4M $481.5M $351.4M
Inventory $606.3M $612.5M $581.4M $530.7M $489.4M $490.6M $381.1M $457.2M $284.0M
Total Current Assets $1.91B $1.59B $1.38B $1.41B $1.52B $1.55B $1.21B $1.29B $771.9M
Property, Plant & Equipment, Net $442.9M $424.9M $447.6M $469.8M $514.2M $477.8M $478.0M $544.1M $486.8M
Goodwill $595.5M $597.4M $598.6M $598.9M $593.0M $522.8M $419.5M $426.2M $26.44M
Intangible Assets $563.5M $732.4M $890.4M $1.10B $1.17B $1.30B $1.38B $1.65B $44.60M
Other Non-Current Assets $57.80M $60.13M $55.52M $103.2M $20.61M $22.34M $44.27M $67.59M $11.26M
Total Non-Current Assets $1.77B $1.91B $2.09B $2.39B $2.42B $2.45B $2.46B $3.07B $570.0M
Total Assets $3.68B $3.50B $3.47B $3.80B $3.94B $4.01B $3.67B $4.35B $1.34B
Accounts Payable -- $258.7M $143.6M $166.0M $131.1M $153.1M $103.0M $114.8M $70.01M
Short-Term Debt $6.76M $224.2M $34.12M $29.96M $30.61M $44.23M $21.48M $21.45M $89.17M
Total Current Liabilities $881.6M $1.13B $846.6M $752.8M $677.2M $676.9M $550.4M $553.9M $296.9M
Long-Term Debt $2.57B $2.16B $2.39B $2.59B $2.68B $2.74B $2.61B $2.63B $1.36B
Other Non-Current Liabilities -- -- -- $87.47M $38.90M $83.36M $39.58M $38.78M $7.79M
Total Non-Current Liabilities $2.79B $2.42B $2.56B $2.84B $2.88B $2.97B $2.77B $2.90B $1.42B
Total Liabilities $3.67B $3.55B $3.41B $3.59B $3.56B $3.65B $3.32B $3.46B $0
Total Debt (incl. Leases) $2.69B $2.49B $2.53B $2.75B $2.84B $2.91B $2.77B $2.75B $1.48B
Common Stock -- -- -- -- -- -- -- -- $10
Retained Earnings -$535.0M -$607.1M -$490.2M -$406.2M -$276.2M -$286.8M -$377.9M -$20.92M -$382.8M
Accumulated Other Comp. Income -$110.7M -$65.51M -$32.35M $9.94M -$24.83M -$41.32M -$68K -$7.75M -$14.23M
Total Stockholders' Equity -$70.79M -$109.3M $19.78M $298.4M $360.3M $303.3M $232.0M $504.8M $0
Total Equity -$71.33M -$109.5M $20.01M $184.0M $367.0M $344.9M $346.8M $896.4M $0

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $157.4M $127.6M $197.7M $282.0M $201.2M $71.54M $59.19M $110.6M
Cash & Short-Term Investments $157.4M $127.6M $197.7M $282.0M $201.2M $71.54M $59.19M $110.6M
Inventory $708.0M $678.0M $641.6M $606.3M $614.5M $609.0M $601.4M $612.5M
Total Current Assets $2.10B $1.95B $1.80B $1.91B $1.84B $1.58B $1.51B $1.59B
Property, Plant & Equipment, Net $572.6M $456.9M $444.6M $442.9M $435.0M $440.3M $427.2M $424.9M
Goodwill $772.5M $593.5M $593.8M $595.5M $595.9M $597.4M $597.5M $597.4M
Intangible Assets $1.55B $587.8M $534.9M $563.5M $587.9M $649.5M $689.1M $732.4M
Other Non-Current Assets $122.8M $80.67M $54.88M $57.80M $39.46M $44.85M $45.42M $60.13M
Total Non-Current Assets $3.17B $1.83B $1.74B $1.77B $1.76B $1.84B $1.85B $1.91B
Total Assets $5.27B $3.78B $3.54B $3.68B $3.60B $3.42B $3.37B $3.50B
Accounts Payable -- -- -- -- $266.4M $205.8M $192.5M $258.7M
Short-Term Debt $23.93M $5.96M $6.20M $6.76M $7.20M $31.18M $31.79M $224.2M
Total Current Liabilities $1.12B $883.2M $728.0M $881.6M $862.1M $1.11B $1.08B $1.13B
Long-Term Debt $2.92B $2.56B $2.57B $2.57B $2.57B $2.15B $2.15B $2.16B
Total Non-Current Liabilities $3.51B $2.78B $2.77B $2.79B $2.78B $2.36B $2.35B $2.42B
Total Liabilities $4.63B $3.66B $3.50B $3.67B $3.64B $3.47B $3.42B $3.55B
Total Debt (incl. Leases) $3.01B $2.57B $2.57B $2.69B $2.57B $2.18B $2.19B $2.49B
Retained Earnings -$436.8M -$415.1M -$472.7M -$535.0M -$570.1M -$572.5M -$594.9M -$607.1M
Accumulated Other Comp. Income -$83.08M -$100.7M -$112.2M -$110.7M -$105.9M -$97.43M -$85.74M -$65.51M
Total Stockholders' Equity $531.3M $33.02M -$45.41M -$70.79M -$109.5M -$112.1M -$131.7M -$109.3M
Total Equity $531.3M $33.02M -$45.97M -$71.33M -$110.0M -$112.5M -$132.0M -$109.5M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income $127.9M -$73.88M -$48.72M -$254.8M $20.17M $68.58M -$603.6M -$201.3M $169.3M $209.4M
Depreciation & Amortization $223.6M $236.2M $229.4M $240.2M $233.4M $235.4M $207.2M $208.4M $114.9M $33.02M
Stock-Based Compensation $31.95M $27.77M $26.82M $31.85M $28.41M $20.75M $21.68M $167.6M $0 $0
Change in Receivables -$120.6M -$162.6M $126.3M -$79.72M -$23.62M $16.79M -$132.7M $89.08M $35.26M -$122.5M
Change in Inventory -$87.03M -$130.5M -$126.2M -$102.4M -$49.02M -$113.8M -$20.39M -$42.02M -$31.83M -$42.59M
Operating Cash Flow $340.0M $295.1M $345.6M $65.10M $241.8M $379.0M $1.71M $250.2M $234.2M $115.1M
Capital Expenditure -$70.06M -$51.92M -$43.22M -$46.41M -$47.73M -$56.45M -$47.18M -$83.09M -$94.77M -$122.8M
Free Cash Flow $269.9M $243.2M $302.4M $18.69M $194.1M $322.6M -$45.48M $167.1M $139.4M -$7.70M
Acquisitions, Net -- $0 $0 -$84.71M -$146.5M -$251.4M $0 -$324.6M $0 $0
Investing Cash Flow -$112.3M -$63.00M -$69.19M -$174.3M -$194.2M -$317.5M -$19.58M -$396.4M -$98.55M -$124.6M
Share Repurchases -- -- -- -- -- -- -- -- -- -$5.0K
Dividends Paid -- -- -- -- -- $0 $0 -$183.0M -$375.3M -$200.6M
Financing Cash Flow -$31.53M -$211.8M -$212.6M -$106.6M -$138.1M $131.8M -$45.83M $287.7M -$95.02M -$19.50M
Net Change in Cash $194.5M $19.31M $63.88M -$221.5M -$90.38M $194.3M -$65.96M $140.9M $40.38M -$27.56M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income $12.31M $69.61M $78.00M $49.57M $18.13M $35.61M $24.62M -$20.74M
Depreciation & Amortization $53.30M -- -- -- $54.10M -- -- --
Stock-Based Compensation $10.52M $10.39M $8.82M $8.20M $8.22M $8.27M $7.26M $7.21M
Change in Receivables $3.34M -$169.8M $44.01M -$10.34M -$77.61M -$53.76M $21.15M -$28.61M
Change in Inventory -$34.20M -$69.19M -$54.96M -$20.18M -$30.81M -$22.78M -$13.26M -$51.98M
Operating Cash Flow $98.30M -$21.24M -$26.74M $130.3M $118.5M $83.82M $7.41M $118.1M
Capital Expenditure -$31.79M -$30.70M -$8.18M -$21.77M -$12.30M -$22.83M -$13.16M -$15.15M
Free Cash Flow $66.51M -$51.94M -$34.92M $108.5M $106.2M $60.99M -$5.75M $102.9M
Investing Cash Flow -$472.2M -$122.7M -$21.71M -$45.45M -$22.46M -$26.55M -$17.80M -$16.06M
Financing Cash Flow $415.2M $79.36M -$59.05M -$10.12M $59.44M -$41.69M -$39.17M -$61.20M
Net Change in Cash $40.63M -$64.79M -$108.5M $74.53M $154.7M $15.28M -$50.03M $40.08M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 36.9% 36.5% 34.3% 35.5% 36.7% 31.5% 21.7% 43.1% 50.9% 58.7%
Operating Margin 13.1% 8.9% 8.5% -4.3% 7.3% 4.6% -15.3% -1.2% 23.7% 28.0%
Net Profit Margin 2.4% -4.2% -3.5% -12.2% 0.6% 3.4% -37.1% -1.2% 0.0% 0.0%
Return on Equity (ROE) -- -- -424.6% -90.7% 3.7% 22.4% -260.1% -3.9% -- --
Return on Assets (ROA) 2.0% -3.3% -2.4% -7.1% 0.3% 1.7% -16.5% -0.5% 0.0% --
Current Ratio 2.17x 1.41x 1.63x 1.88x 2.24x 2.29x 2.20x 2.32x 2.60x --
Quick Ratio 1.48x 0.86x 0.94x 1.17x 1.52x 1.57x 1.51x 1.50x 1.64x --
Debt to Equity -- -- 127.90x 9.20x 7.88x 9.59x 11.92x 5.45x -- --
Revenue Growth (YoY) +8.0% +16.7% +8.2% +5.7% +5.1% +22.5% -2.2% +60.9% +1.5% --
Gross Profit Growth (YoY) +9.1% +24.4% +4.6% +2.0% +22.4% +78.0% -50.7% +36.2% -11.9% --
Operating Income Growth (YoY) +58.1% +22.0% -- -162.2% +67.5% -- -- -108.0% -14.0% --
Net Income Growth (YoY) -- -- -- -2155.6% -80.6% -- -- -- -- --
EPS Growth (YoY) -- -- -- -1328.6% -88.7% -- -- -- -- --
Operating Cash Flow Growth (YoY) +15.2% -14.6% +430.8% -73.1% -36.2% +22128.8% -99.3% +6.9% +103.5% --
Free Cash Flow Growth (YoY) +11.0% -19.6% +1517.5% -90.4% -39.8% -- -127.2% +19.9% -- --
5Y Revenue / Share Growth -28.7% -26.5% +4.0% -- -- -- -- -- -- --
5Y Net Income / Share Growth -50.0% -- -- -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin 40.2% 39.3% 38.7% 36.9% 36.8% 37.7% 36.7% 36.5%
Operating Margin 15.0% 14.6% 14.3% 13.1% 12.2% 13.2% 12.7% 8.9%
Net Profit Margin 4.2% 5.0% 4.0% 2.4% 0.2% 0.1% -0.5% -4.2%
Return on Equity (ROE) 25.1% 476.5% -- -- -- -- -- --
Return on Assets (ROA) 2.5% 4.2% 3.4% 2.0% 0.2% 0.1% -0.4% -3.3%
Current Ratio 1.87x 2.20x 2.47x 2.17x 2.13x 1.43x 1.40x 1.41x
Quick Ratio 1.24x 1.44x 1.59x 1.48x 1.42x 0.88x 0.84x 0.86x
Debt to Equity 5.66x 77.83x -- -- -- -- -- --
Revenue Growth (YoY) +10.0% +9.9% +3.9% +11.5% +11.7% +3.2% +5.5% +18.4%
Gross Profit Growth (YoY) +22.0% +16.9% +25.1% +13.1% +1.6% +14.5% +7.5% +38.5%
Operating Income Growth (YoY) +35.6% +16.5% +41.3% +47.8% -20.8% +16.7% -- +434.0%
Net Income Growth (YoY) -1015.8% +157.2% +410.5% -- -- +274.0% -- --
EPS Growth (YoY) -700.0% +157.1% +400.0% -- -- +250.0% -- --
Operating Cash Flow Growth (YoY) -17.0% -125.3% -461.0% +10.4% -16.5% +111.4% -- -13.1%
Free Cash Flow Growth (YoY) -37.3% -185.2% -- +5.5% -15.0% +110.1% -- -18.3%
Source: SEC EDGAR CompanyFacts (CIK 0001723128) · from December 31, 2016 Data through September 30, 2026 · synced Nov 20, 2026, 05:11 UTC · Open in terminal